CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The new online Learning Center with new content can still be found under the “Training” folder on ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...